BRIEF published on 06/09/2026 at 08:05, 1 month 19 days ago Industry stakeholders united to raise awareness of Batten disease Partnership Clinical Study Awareness Batten Disease THX Pharma
BRIEF published on 06/09/2026 at 08:04, 1 month 19 days ago Molten Ventures Reports £238m Valuation Uplift Following ICEYE Series F Financing Satellite Technology Molten Ventures Valuation Uplift ICEYE Series F European Tech Investment
BRIEF published on 06/09/2026 at 08:04, 1 month 19 days ago Molten Ventures annonce une valorisation revue à la hausse de 238 millions de livres sterling suite à son financement de série F par ICEYE. Molten Ventures Technologie Satellitaire Revalorisation Série ICEYE F Investissements Technologiques Européens
BRIEF published on 06/09/2026 at 08:00, 1 month 19 days ago Fireaway Receives Certifications for Stat-X Fire-Extinguishing Systems Type Approval Bureau Veritas Stat-X Systems SOLAS Compliance Marine Certification
BRIEF published on 06/09/2026 at 08:00, 1 month 19 days ago Fireaway obtient les certifications pour ses systèmes d'extinction d'incendie Stat-X Homologation De Type Bureau Veritas Systèmes Stat-X Conformité SOLAS Certification Maritime
BRIEF published on 06/09/2026 at 07:54, 1 month 19 days ago K+S Aktiengesellschaft Unveils €300 Million Convertible Bonds Offering Convertible Bonds Institutional Investors K+S Aktiengesellschaft Bond Redemption Salt Business Acquisition
BRIEF published on 06/09/2026 at 07:54, 1 month 19 days ago K+S Aktiengesellschaft dévoile une offre d'obligations convertibles de 300 millions d'euros Obligations Convertibles Investisseurs Institutionnels Rachat D'obligations K+S Aktiengesellschaft Acquisition De Salt Business
BRIEF published on 06/09/2026 at 07:50, 1 month 19 days ago Pentixapharm Holding AG Advances with FDA Approval and Capital Increase Plan FDA Approval Capital Increase Primary Aldosteronism PANDA Study BaFin Review
BRIEF published on 06/09/2026 at 07:50, 1 month 19 days ago Pentixapharm Holding AG franchit une étape importante avec l'approbation de la FDA et son plan d'augmentation de capital Augmentation De Capital Approbation De La FDA Aldostéronisme Primaire Étude PANDA Revue De La BaFin
BRIEF published on 06/09/2026 at 07:46, 1 month 19 days ago RAG-Stiftung Announces Exchangeable Bond Offering Institutional Investors Financial Strategy Evonik Industries Exchangeable Bonds RAG-Stiftung
Published on 07/28/2026 at 16:55, 33 minutes ago Unusual Machines Announces Record Date for 2026 Annual Meeting
Published on 07/28/2026 at 15:00, 2 hours 28 minutes ago Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Published on 07/28/2026 at 14:45, 2 hours 43 minutes ago Trifecta Gold Introduces the Liam and Lois Projects, East-Central Yukon and Grants Stock Options
Published on 07/28/2026 at 14:30, 2 hours 58 minutes ago Sekur Private Data Reports 25% Month-Over-Month Increase in Average Revenue Per User as Premium Pivot Takes Hold
Published on 07/28/2026 at 16:32, 56 minutes ago Modalités de mise à disposition ou de consultation des documents préparatoires vis à vis de l'AG du 30/09/26
Published on 07/28/2026 at 16:18, 1 hour 9 minutes ago Ordre du jour et projet de texte des résolutions de l'AG du 30/09/26 en Anglais
Published on 07/28/2026 at 15:18, 2 hours 10 minutes ago Tableau récapitulatif des délégations relatives aux augmentations de capital au 31/03/26
